ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
5,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5,3,Enterocolitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,Y
5,4,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
5,5,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
5,6,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5,7,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
6,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
7,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
7,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
7,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
7,4,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
7,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
8,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
9,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
9,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
10,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
11,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
12,1,Airway complication of anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
12,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
13,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
13,2,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
14,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
14,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
14,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
14,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
14,5,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
14,6,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
14,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
14,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
15,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
15,2,Headache,Headaches NEC,Headaches,Nerv,N
15,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
15,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
16,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
17,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
18,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
18,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
18,3,Metastases to eye,Metastases to specified sites,Metastases,Neopl,N
18,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
19,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
19,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
19,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
19,4,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,Y
19,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
20,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
20,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
20,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
20,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
21,1,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
22,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
22,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
22,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,Y
22,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
23,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
23,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
23,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
24,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
25,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
25,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
26,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
27,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
28,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
28,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
28,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
28,4,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
28,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
29,1,VIth nerve disorder,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
30,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
30,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
30,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
31,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
31,2,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
32,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
33,1,Metastases to liver,Metastases to specified sites,Metastases,Neopl,Y
34,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
34,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
34,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
34,4,Endocrine disorder,Endocrine disorders NEC,Endocrine and glandular disorders NEC,Endo,N
34,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
34,6,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
34,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
34,8,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
34,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
35,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
35,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
35,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
36,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
36,2,Headache,Headaches NEC,Headaches,Nerv,N
36,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
37,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
38,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
39,1,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
40,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
41,1,Abdominal neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
41,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
42,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
42,2,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
43,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
44,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
44,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
44,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
45,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
46,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
46,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
47,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
48,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
48,2,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
49,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
49,2,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
49,3,Cortisol increased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
49,4,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
49,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
49,6,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
49,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
49,8,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
49,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
49,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
49,11,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
50,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
50,2,Endocrine disorder,Endocrine disorders NEC,Endocrine and glandular disorders NEC,Endo,N
50,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
51,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
51,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
51,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
51,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
52,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
52,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
53,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
53,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
53,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
53,4,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
54,1,Diarrhoea infectious,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
54,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
55,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
55,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
55,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
56,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
56,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
56,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
56,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
57,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
57,2,Enterocolitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
57,3,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
57,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
58,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
58,2,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
59,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
59,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
60,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
60,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
60,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
61,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
61,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
61,3,Peptic ulcer,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
62,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
62,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
62,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
62,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
62,5,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
62,6,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
62,7,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
62,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
63,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
64,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
65,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
65,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
66,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
67,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
67,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
68,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
69,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
70,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
70,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
71,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
71,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
71,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
72,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
73,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
74,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
74,2,Metastases to skin,Metastases to specified sites,Metastases,Neopl,N
75,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
75,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
75,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
75,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
76,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
76,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
77,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
77,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
77,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
77,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
78,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
78,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
78,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
79,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
79,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
80,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
80,2,Hypothalamo-pituitary disorder,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
80,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
81,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
81,2,Hypothalamo-pituitary disorder,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
81,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
82,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
82,2,Hypothalamo-pituitary disorder,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
82,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
83,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
83,2,Hypothalamo-pituitary disorder,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
83,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
84,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
85,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
85,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
85,3,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
86,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
87,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
87,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
87,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
88,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
88,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
88,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
88,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
89,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
89,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
89,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
89,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
90,1,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
90,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
90,3,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
91,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
91,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
92,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
93,1,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
93,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
93,3,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
93,4,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
94,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
95,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
95,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
96,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
97,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
97,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
98,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
98,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
98,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
99,1,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
100,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
101,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
102,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
102,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
103,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
103,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
103,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
104,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
104,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
105,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
105,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
106,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
107,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
108,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
108,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
109,1,Blood testosterone decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
109,2,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
109,3,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
109,4,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
110,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
111,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
111,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
111,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
111,4,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
111,5,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
111,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
111,7,Neurological examination abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
111,8,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
111,9,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
111,10,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
112,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
113,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
113,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
114,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
115,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
115,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
115,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
116,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
116,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
116,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
117,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
118,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
119,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
120,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
121,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
122,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
122,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
122,3,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
122,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
122,5,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
123,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
123,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
123,3,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
123,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
124,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
124,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
124,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
124,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
124,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
124,6,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
124,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
124,8,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
124,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
125,1,Adenocarcinoma of colon,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
125,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
125,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
126,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
126,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
126,3,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
126,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
127,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
127,2,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
128,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
128,2,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
128,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
128,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
128,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
129,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
129,2,Headache,Headaches NEC,Headaches,Nerv,N
129,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
129,4,Hypothalamo-pituitary disorder,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
129,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
129,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
129,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
129,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
130,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
131,1,Portal vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
132,1,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,Y
132,2,Strangulated hernia,Hernias NEC,General system disorders NEC,Genrl,N
133,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
133,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
133,3,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
134,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
135,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
135,2,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
136,1,Atypical pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
137,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
137,2,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
137,3,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
138,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,Y
138,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
139,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
140,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
140,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
141,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
141,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
141,3,Headache,Headaches NEC,Headaches,Nerv,N
141,4,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
141,5,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
141,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
142,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
142,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
143,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
144,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
144,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
144,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
145,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
146,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
146,2,Nephritis,Nephritis NEC,Nephropathies,Renal,N
146,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
147,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
148,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
148,2,Headache,Headaches NEC,Headaches,Nerv,N
148,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
149,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
149,2,Chorioretinitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
149,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
150,1,Headache,Headaches NEC,Headaches,Nerv,N
150,2,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
150,3,Retinal disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
150,4,Subretinal fluid,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
150,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
151,1,Dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
152,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
152,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
152,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
153,1,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
153,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
153,3,Gastrointestinal necrosis,Gastrointestinal necrosis and gangrene (excl gangrenous hernia),Gastrointestinal vascular conditions,Gastr,N
153,4,Megacolon,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
153,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
153,6,Volvulus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
154,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
154,2,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
155,1,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
156,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
156,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
156,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
156,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
156,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
157,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
157,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
157,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
157,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
157,5,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
157,6,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
157,7,Megacolon,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
158,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
159,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
160,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
161,1,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
162,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
162,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
163,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
163,2,Alanine aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
163,3,Blood alkaline phosphatase abnormal,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
163,4,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
163,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
163,6,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
163,7,Inflammation,Inflammations,General system disorders NEC,Genrl,N
163,8,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
164,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
164,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
164,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
164,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
165,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
165,2,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
166,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
167,1,Alopecia totalis,Alopecias,Skin appendage conditions,Skin,N
168,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
169,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
169,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
170,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
171,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
171,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
172,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
173,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
173,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
174,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
175,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
176,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
176,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
177,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
177,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
178,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
178,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
179,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
180,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
180,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
181,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
181,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
181,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
181,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
181,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
181,6,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
181,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
182,1,Arterial injury,Cardiovascular injuries,Injuries NEC,Inj&P,N
182,2,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
182,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
182,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
182,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
182,6,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,Y
182,7,Pulse absent,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
182,8,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
183,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
183,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
183,3,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
183,4,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
184,1,Pituitary enlargement,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
185,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
186,1,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
186,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
186,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
186,4,Headache,Headaches NEC,Headaches,Nerv,N
186,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
186,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
186,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
186,8,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
187,1,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
187,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
187,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
188,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
189,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
189,2,Enterocolitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
189,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
190,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
190,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
190,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
190,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
191,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
191,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
192,1,Neuropathic muscular atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
193,1,Blood testosterone abnormal,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
193,2,Hypothalamo-pituitary disorder,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
193,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
194,1,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
194,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
194,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
194,4,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
195,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
195,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
195,3,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
196,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
197,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
197,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
198,1,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
198,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
199,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
199,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
199,3,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
200,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
201,1,Blood thyroid stimulating hormone decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
201,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
201,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
202,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
202,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
203,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
204,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
204,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
204,3,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
205,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
206,1,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
206,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
206,3,Laparotomy,Abdominal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
206,4,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
206,5,Myopathy,Myopathies,Muscle disorders,Musc,N
206,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
206,7,Wound dehiscence,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
207,1,Endocrine disorder,Endocrine disorders NEC,Endocrine and glandular disorders NEC,Endo,N
207,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
207,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
208,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
208,2,Endocrine disorder,Endocrine disorders NEC,Endocrine and glandular disorders NEC,Endo,N
208,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
208,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
208,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
209,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
209,2,Endocrine disorder,Endocrine disorders NEC,Endocrine and glandular disorders NEC,Endo,N
209,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
209,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
210,1,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
210,2,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
210,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
210,4,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
211,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
212,1,Haemodialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
212,2,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
212,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
213,1,Endocrine disorder,Endocrine disorders NEC,Endocrine and glandular disorders NEC,Endo,N
213,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
213,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
214,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
214,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
214,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
214,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
214,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
214,6,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
214,7,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
214,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
214,9,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
214,10,Motor neurone disease,Motor neurone diseases,Neuromuscular disorders,Nerv,N
214,11,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
214,12,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
214,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
214,14,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
214,15,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
214,16,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
214,17,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
214,18,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
215,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
216,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
217,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
218,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
218,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
218,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
218,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
219,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
220,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
221,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
222,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
223,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
224,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
225,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
226,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
227,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
228,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
229,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
230,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
231,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
232,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
233,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
234,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
235,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
236,1,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
236,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
237,1,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
237,2,Glioblastoma,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,Y
237,3,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
237,4,Irregular breathing,Breathing abnormalities,Respiratory disorders NEC,Resp,N
237,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
237,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
238,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
239,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
240,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
241,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
242,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
243,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
244,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
245,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
246,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
246,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
247,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
247,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
247,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
248,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
248,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
249,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
249,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
250,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
250,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
251,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
251,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
252,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
252,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
253,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
253,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
254,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
255,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
256,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
257,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
257,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
258,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
258,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
258,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
258,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
258,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
258,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
258,7,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
258,8,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
259,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
259,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
259,3,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
259,4,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
259,5,Intestinal sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
259,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
260,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
261,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
262,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
263,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
263,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
263,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
264,1,Dialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
264,2,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
264,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
264,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
265,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
266,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
266,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
267,1,Fungal sepsis,Fungal infections NEC,Fungal infectious disorders,Infec,N
267,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
267,3,Myopathy,Myopathies,Muscle disorders,Musc,N
268,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
269,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
270,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
270,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
270,3,Headache,Headaches NEC,Headaches,Nerv,N
270,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
271,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
271,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
272,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
272,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
273,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
274,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
275,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
275,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
275,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
275,4,Headache,Headaches NEC,Headaches,Nerv,N
275,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
275,6,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
275,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
275,8,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
275,9,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
275,10,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
275,11,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
275,12,Thyroxine decreased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
275,13,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
275,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
275,15,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
276,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
277,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
277,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
277,3,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
277,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
278,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
278,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
278,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
279,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
280,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
280,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
281,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
281,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
281,3,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
282,1,Nephritis,Nephritis NEC,Nephropathies,Renal,N
283,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
283,2,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
284,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
284,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
284,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
284,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
284,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
284,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
285,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
285,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
285,3,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
285,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
286,1,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
287,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
287,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
287,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
287,4,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
288,1,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
288,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
288,3,Ileostomy,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
289,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
289,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
289,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
289,4,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
289,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
290,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
290,2,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
290,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
290,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
290,5,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
290,6,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
291,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
292,1,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
293,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
293,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
293,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
293,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
293,5,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
294,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
295,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
295,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
295,3,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
296,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
296,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
296,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
296,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
297,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
297,2,Headache,Headaches NEC,Headaches,Nerv,N
297,3,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
297,4,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
298,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
298,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
298,3,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
299,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
299,2,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
299,3,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
299,4,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
299,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
299,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
300,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
300,2,Clostridium test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
300,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
300,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
300,5,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
300,6,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
300,7,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
300,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
300,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
300,10,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
301,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
301,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
301,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
302,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
302,2,Thyroglobulin increased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
303,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
303,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
303,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
303,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
303,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
304,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
304,2,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
304,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
304,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
304,5,Inflammation,Inflammations,General system disorders NEC,Genrl,N
304,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
304,7,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
304,8,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
305,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
305,2,Headache,Headaches NEC,Headaches,Nerv,N
305,3,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
305,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
305,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
306,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
306,2,Myasthenic syndrome,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
307,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
307,2,Pancreatic neoplasm,Gastrointestinal neoplasms malignancy unspecified NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
308,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
308,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
308,3,Polymyositis,Muscle infections and inflammations,Muscle disorders,Musc,N
308,4,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
309,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
310,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
311,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
311,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
311,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
311,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
311,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
311,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
312,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
312,2,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
312,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
312,4,Seronegative arthritis,Arthropathies NEC,Joint disorders,Musc,N
313,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
314,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
314,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
314,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
315,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
315,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
316,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
316,2,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
316,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
317,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
317,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
317,3,Bulbar palsy,Mixed cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
317,4,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
317,5,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
317,6,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
317,7,Plasmapheresis,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
317,8,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
317,9,Tracheostomy,Tracheal therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
318,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
318,2,Craniotomy,Skull and brain therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
318,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
319,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
319,2,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
319,3,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
320,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
320,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
321,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
322,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
322,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
323,1,Bulbar palsy,Mixed cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
323,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
323,3,Phrenic nerve paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
324,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
325,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
326,1,Allergic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
326,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
326,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
327,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
327,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
327,3,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
328,1,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
328,2,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
329,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
329,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
329,3,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
330,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
331,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
332,1,Exposure via body fluid,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
332,2,Pregnancy on contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
333,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
334,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
334,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
335,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
336,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
337,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
338,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
339,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
340,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
341,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
342,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
343,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
344,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
345,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
346,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
346,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
346,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
347,1,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
348,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
349,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
350,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
350,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
350,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
350,4,Headache,Headaches NEC,Headaches,Nerv,N
350,5,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
350,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
351,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
351,2,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
352,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
352,2,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
353,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
353,2,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
354,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
354,2,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
355,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
355,2,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
356,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
356,2,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
357,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
357,2,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
358,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
359,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
359,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
359,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
360,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
361,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
361,2,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
361,3,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
362,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
363,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
364,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
364,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
364,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
365,1,Alanine aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
366,1,Glucocorticoid deficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
366,2,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
367,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
367,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
367,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
368,1,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
368,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
368,3,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
368,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
369,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
370,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
370,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
371,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
372,1,Atelectasis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
372,2,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
373,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
374,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
374,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
375,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
376,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
377,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
378,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
379,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
380,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
380,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
380,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
381,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
381,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
381,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
381,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
381,5,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
381,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
381,7,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
381,8,Malignant splenic neoplasm,Haematologic neoplasms NEC,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
381,9,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
381,10,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
381,11,Metastases to breast,Metastases to specified sites,Metastases,Neopl,N
381,12,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
381,13,Metastases to stomach,Metastases to specified sites,Metastases,Neopl,N
381,14,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
381,15,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
381,16,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
381,17,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
381,18,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
381,19,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
382,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
382,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
382,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
382,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
382,5,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
382,6,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
383,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
384,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
384,2,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
384,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
384,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
384,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
384,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
385,1,Blood pressure immeasurable,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
385,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
385,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
385,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
385,5,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
385,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
386,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
387,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
387,2,Cortisol abnormal,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
387,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
387,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
387,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
387,6,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
387,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
388,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
388,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
389,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
389,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
390,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
390,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
390,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
391,1,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
391,2,Autoimmune myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,Y
391,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
391,4,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
391,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
391,6,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
391,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
391,8,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
391,9,Trifascicular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
392,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
393,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
393,2,Autoimmune thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
393,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
393,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
394,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
395,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
396,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
397,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
397,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
397,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
397,4,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
397,5,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
397,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
397,7,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
397,8,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
397,9,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
397,10,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
397,11,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
397,12,Thyrotoxic crisis,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
398,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
398,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
398,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
398,4,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
398,5,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
398,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
398,7,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
398,8,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
398,9,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
398,10,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
398,11,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
398,12,Thyrotoxic crisis,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
398,13,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
399,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
400,1,Adrenalitis,Infections NEC,Infections - pathogen unspecified,Infec,N
400,2,Autoimmune nephritis,Nephritis NEC,Nephropathies,Renal,N
400,3,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
400,4,Pituitary infarction,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
401,1,Body temperature fluctuation,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
401,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
401,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
401,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
401,5,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
401,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
401,7,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
401,8,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
401,9,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
401,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
401,11,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
401,12,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
401,13,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
401,14,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
401,15,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
402,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
403,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
404,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
404,2,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
404,3,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
404,4,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
404,5,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
404,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
404,7,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
404,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
405,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
406,1,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
406,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
406,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
406,4,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
406,5,Lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
406,6,Protein total increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
406,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
406,8,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
407,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
407,2,Lip erosion,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
407,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
407,4,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
407,5,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
408,1,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
408,2,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
408,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
408,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
409,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
410,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
410,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
410,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
410,4,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
410,5,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
411,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
411,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
411,3,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
411,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
411,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
411,6,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
411,7,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
411,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
411,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
412,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
413,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
413,2,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
413,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
413,4,Sputum abnormal,Respiratory tract and thoracic histopathology procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
414,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
415,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
415,2,Herpes simplex test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
415,3,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
415,4,Leptospirosis,Leptospira infections,Bacterial infectious disorders,Infec,N
415,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
415,6,Penile ulceration,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
416,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
417,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
418,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
418,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
418,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
418,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
419,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
419,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
419,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
419,4,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
420,1,Adrenal disorder,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,N
420,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
420,3,Glucocorticoid deficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
420,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
421,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
422,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
423,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
423,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
423,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
424,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
425,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
425,2,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
426,1,Immune-mediated adverse reaction,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
427,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
427,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
428,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
428,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
428,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
428,4,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
429,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
429,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
429,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
430,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
430,2,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
430,3,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,N
430,4,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
431,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
431,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
431,3,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
432,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
432,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
432,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
432,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
432,5,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
433,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
433,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
433,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
433,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
434,1,Autoimmune uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
434,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
435,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
436,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
437,1,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
437,2,Megacolon,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
438,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
438,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
438,3,Headache,Headaches NEC,Headaches,Nerv,N
438,4,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
438,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
439,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
440,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
440,2,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
440,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
440,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
440,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
441,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
441,2,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
442,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
442,2,Epstein Barr virus positive mucocutaneous ulcer,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
443,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
443,2,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
443,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
444,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
444,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
445,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
445,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
445,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
446,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
446,2,Encephalitis autoimmune,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
447,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
447,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
447,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
447,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
447,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
448,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
449,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
450,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
450,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
450,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
450,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
450,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
450,6,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
450,7,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
450,8,Oral blood blister,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
450,9,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
450,10,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
450,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
450,12,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
451,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
452,1,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
452,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
452,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
452,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
452,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
453,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
453,2,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
453,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
454,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
455,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
456,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
457,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
458,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
459,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
460,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
460,2,Gastrointestinal bacterial overgrowth,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
460,3,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
460,4,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
461,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
462,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
463,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
464,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
465,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
466,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
467,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
468,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
469,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
470,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
471,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
472,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
472,2,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
472,3,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
472,4,Headache,Headaches NEC,Headaches,Nerv,N
472,5,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
472,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
473,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
473,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
473,3,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
474,1,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
475,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
475,2,Drug monitoring procedure incorrectly performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
475,3,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
476,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
477,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
477,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
477,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
478,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
478,2,Autoimmune nephritis,Nephritis NEC,Nephropathies,Renal,N
479,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
479,2,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
479,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
479,4,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
479,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
479,6,Headache,Headaches NEC,Headaches,Nerv,N
480,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
480,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
480,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
481,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
482,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
483,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
483,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
483,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
483,4,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
483,5,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
484,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
485,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
486,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
486,2,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
487,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
487,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
488,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
488,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
488,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
488,4,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
488,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
488,6,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
488,7,Oral pruritus,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
488,8,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
488,9,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
488,10,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
488,11,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
488,12,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
488,13,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
489,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
490,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
490,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
490,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
490,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
490,5,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
491,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
491,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
492,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
492,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
493,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
493,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
493,3,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
494,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
494,2,Metastases to adrenals,Metastases to specified sites,Metastases,Neopl,N
494,3,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
495,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
496,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
496,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
497,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
498,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
498,2,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
499,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
499,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
500,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
500,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
501,1,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
502,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
502,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
502,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
503,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
503,2,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
504,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
504,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
504,3,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
505,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
505,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
505,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
505,4,Myelopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
506,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
506,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
506,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
507,1,Autoimmune arthritis,Arthropathies NEC,Joint disorders,Musc,N
507,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
508,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
508,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
508,3,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
509,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
509,2,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
510,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
510,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
510,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
511,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
512,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
512,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
512,3,Cytokine storm,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
512,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
512,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
512,6,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
512,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
512,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
512,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
512,10,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
512,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
512,12,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
513,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
513,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
513,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
513,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
513,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
513,6,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
514,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
514,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
514,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
514,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
515,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
515,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
515,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
516,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
517,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
517,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
518,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
518,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
519,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
520,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
521,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
522,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
523,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
523,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
523,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
524,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
524,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
524,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
525,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
525,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
526,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
526,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
527,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
528,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
529,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
529,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
529,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
529,4,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
529,5,Pharyngeal inflammation,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
529,6,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
529,7,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
530,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
530,2,Immune-mediated adverse reaction,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
530,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
531,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
531,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
531,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
531,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
531,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
531,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
531,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
531,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
532,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
533,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
534,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
534,2,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
534,3,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
535,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
535,2,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
535,3,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
536,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
536,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
537,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
537,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
537,3,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
538,1,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
538,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
539,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
540,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
541,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
542,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
543,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
543,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
544,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
545,1,Immune-mediated lung disease,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
546,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
546,2,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
547,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
548,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
548,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
549,1,Autoimmune inner ear disease,Inner ear infections and inflammations,Inner ear and VIIIth cranial nerve disorders,Ear,N
549,2,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
549,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
549,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
549,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
549,6,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
549,7,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
550,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
551,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
551,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
551,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
551,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
551,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
551,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
552,1,Deafness,Hearing losses,Hearing disorders,Ear,N
552,2,Hyperacusis,Hyperacusia,Hearing disorders,Ear,N
552,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
553,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
553,2,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
553,3,Lymphadenopathy mediastinal,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
553,4,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
553,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
553,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
553,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
554,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
554,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
554,3,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
554,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
555,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
555,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
555,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
556,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
557,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
557,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
557,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
558,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
558,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
558,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
558,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
558,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
558,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
559,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
560,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
561,1,Chronic sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
562,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
562,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
562,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
563,1,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
564,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
564,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
565,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
565,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
565,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
565,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
566,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
566,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
566,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
567,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
568,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
568,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
569,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
569,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
570,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
570,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
570,3,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
571,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
571,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
572,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
572,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
573,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
573,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
573,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
573,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
574,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
574,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
574,3,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
574,4,Immune-mediated uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
575,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
575,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
575,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
575,4,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
576,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
577,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
578,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
579,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
580,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
581,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
582,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
583,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,Y
584,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
585,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,Y
586,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
587,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
588,1,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
589,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
589,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
590,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
591,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
592,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
592,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
592,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
592,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
593,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
594,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
595,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
596,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
596,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
597,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
597,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
597,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
598,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
599,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
599,2,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
599,3,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
600,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
601,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
601,2,Pleural disorder,Pleural conditions NEC,Pleural disorders,Resp,N
602,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
603,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
603,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
603,3,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
603,4,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
604,1,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
605,1,Melanosis,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
606,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
606,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
607,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
607,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
607,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
607,4,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
608,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
608,2,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
608,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
608,4,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
608,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
608,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
608,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
608,8,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
608,9,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,Y
608,10,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
609,1,Immune-mediated lung disease,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
610,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
610,2,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
610,3,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
610,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
611,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
611,2,Jejunal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
611,3,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
612,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
612,2,Immune-mediated encephalitis,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
612,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
612,4,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
612,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
612,6,Toxic leukoencephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
613,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
613,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
613,3,Tumour pseudoprogression,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
614,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
615,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
615,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
615,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
615,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
615,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
615,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
616,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
616,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
617,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
618,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
618,2,Thyroiditis acute,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
619,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
620,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
620,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
621,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
622,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
623,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
623,2,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
624,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
624,2,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
624,3,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
625,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
625,2,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
625,3,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
626,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
627,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
628,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
629,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
630,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
630,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
631,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
632,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
632,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
633,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
633,2,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
633,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
634,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
634,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
634,3,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
634,4,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
635,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
635,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
636,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
636,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
636,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
637,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
637,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
638,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
638,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
638,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
639,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
640,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
641,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
641,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
642,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
643,1,Nephritis,Nephritis NEC,Nephropathies,Renal,N
643,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
643,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
644,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
645,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
646,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
647,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
647,2,Nephritis,Nephritis NEC,Nephropathies,Renal,N
647,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
648,1,Ureteric obstruction,Ureteric disorders NEC,Ureteric disorders,Renal,N
649,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
650,1,Glomerulonephritis membranous,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
650,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
651,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
652,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
652,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
652,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
652,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
653,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
653,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
654,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
655,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
656,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
657,1,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
658,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
658,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
658,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
659,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
659,2,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
659,3,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
660,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
661,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
661,2,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
662,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
662,2,Immune-mediated lung disease,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
663,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
663,2,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
664,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
665,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
665,2,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
665,3,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
666,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
666,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
666,3,Tumour haemorrhage,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
667,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
667,2,Tumour pseudoprogression,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
667,3,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
668,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
669,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
669,2,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
669,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
670,1,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
670,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
670,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
671,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
671,2,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
671,3,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
672,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
672,2,Ocular ischaemic syndrome,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
672,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
673,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
674,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
674,2,Retinal melanoma,Ocular melanomas,Ocular neoplasms,Neopl,N
675,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
675,2,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
676,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
676,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
676,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
677,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
677,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
678,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
679,1,Adrenal disorder,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,N
679,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
679,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
679,4,Headache,Headaches NEC,Headaches,Nerv,N
679,5,Hypothalamo-pituitary disorder,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
679,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
680,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
681,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
682,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
683,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
684,1,Bladder neoplasm,Urinary tract neoplasms unspecified malignancy NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
684,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
684,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
685,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
686,1,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
686,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
686,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
686,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
686,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
686,6,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
686,7,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
686,8,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
686,9,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
686,10,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
686,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
686,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
686,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
686,14,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
686,15,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
686,16,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
686,17,Weight fluctuation,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
687,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
688,1,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
688,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
689,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
689,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
690,1,Lymphocytic hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
691,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
691,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
692,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
692,2,Oesophageal achalasia,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
693,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
694,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
695,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
695,2,Immune-mediated myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
695,3,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
695,4,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
696,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
697,1,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
698,1,Vestibular disorder,Inner ear disorders NEC,Inner ear and VIIIth cranial nerve disorders,Ear,N
699,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
699,2,Vestibular disorder,Inner ear disorders NEC,Inner ear and VIIIth cranial nerve disorders,Ear,N
700,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
701,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
702,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
703,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
703,2,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
703,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
703,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
703,5,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
703,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
703,7,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
704,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
705,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
706,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
707,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
707,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
707,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
708,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
709,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
710,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
710,2,Arthropod bite,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
710,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
710,4,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
710,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
710,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
711,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
712,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
713,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
714,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
715,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
716,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
717,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
718,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
719,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
720,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
721,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
722,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
723,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
724,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
725,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
726,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
727,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
728,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
729,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
730,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
731,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
732,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
733,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
734,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
735,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
736,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
737,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
738,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
739,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
740,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
741,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
742,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
743,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
744,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
745,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
746,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
747,1,Immune-mediated myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
747,2,Soft tissue haemorrhage,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,Y
748,1,Immune-mediated myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
749,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
750,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
751,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
751,2,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
752,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
752,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
752,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
753,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
753,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
753,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
753,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
753,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
754,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
754,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
755,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
756,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
757,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
757,2,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
757,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
757,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
757,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
757,6,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
757,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
757,8,Gingival abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
757,9,Headache,Headaches NEC,Headaches,Nerv,N
757,10,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
757,11,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
757,12,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
757,13,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
757,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
757,15,Rheumatic disorder,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
757,16,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
758,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
758,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
759,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
760,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
760,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
760,3,Nephritis,Nephritis NEC,Nephropathies,Renal,N
760,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
761,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
762,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
763,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
763,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
764,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
764,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
765,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
765,2,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
766,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
766,2,Dry gangrene,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
766,3,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
767,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
767,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
768,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
768,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
768,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
769,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
769,2,Glucocorticoid deficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
769,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
769,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
769,5,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
770,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
770,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
770,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
770,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
770,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
771,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
771,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
771,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
771,4,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
771,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
772,1,Acute motor-sensory axonal neuropathy,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
772,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
772,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
772,4,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
772,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
772,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
772,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
772,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
773,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
774,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
774,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
774,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
774,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
775,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
776,1,Endocrine disorder,Endocrine disorders NEC,Endocrine and glandular disorders NEC,Endo,N
777,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
778,1,Intussusception,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
779,1,Immune-mediated myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
779,2,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
780,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
781,1,Cholangitis sclerosing,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
781,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
782,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
783,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
784,1,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
784,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
784,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
784,4,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
784,5,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
784,6,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
784,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
784,8,Seborrhoeic keratosis,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
785,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
785,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
785,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
785,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
785,5,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
785,6,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
786,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
786,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
787,1,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
788,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
788,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
788,3,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
789,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
789,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
789,3,Renal vein thrombosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
790,1,Melanoma recurrent,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
791,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
791,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
791,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
792,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
792,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
793,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
794,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
795,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
795,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
796,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
796,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
796,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
797,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
798,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
798,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
798,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
798,4,Immune-mediated myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,Y
799,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
800,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
800,2,Immune-mediated neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
801,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
801,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
802,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
802,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
803,1,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
804,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
805,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
806,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
806,2,Balanoposthitis,Penile and scrotal infections and inflammations,Male reproductive tract infections and inflammations,Repro,N
806,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
806,4,Immune-mediated dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
806,5,Immune-mediated nephritis,Nephritis NEC,Nephropathies,Renal,N
806,6,Post procedural pulmonary embolism,Respiratory tract and thoracic cavity procedural complications,Procedural related injuries and complications NEC,Inj&P,N
806,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
807,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
808,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
808,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
808,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
808,4,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
808,5,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
809,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
810,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
811,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
812,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
813,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
813,2,Immune-mediated dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
813,3,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
813,4,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
813,5,Immune-mediated thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
813,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
813,7,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
813,8,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
813,9,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
814,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
815,1,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
816,1,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
817,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
818,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
819,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
819,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
820,1,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
821,1,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
821,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
822,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
823,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
824,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
825,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
826,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
827,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
827,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
828,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
829,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
830,1,Nephritis,Nephritis NEC,Nephropathies,Renal,N
831,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,Y
832,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
832,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
833,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
834,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
834,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
834,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
835,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
836,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
837,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
838,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
839,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
840,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
841,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
842,1,Cholangitis sclerosing,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
842,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
843,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
844,1,Immune-mediated neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
845,1,Dependence on respirator,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
845,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
845,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
845,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
845,5,Myasthenic syndrome,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,Y
845,6,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
845,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
845,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
846,1,Epilepsia partialis continua,Partial simple seizures NEC,Seizures (incl subtypes),Nerv,N
847,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
848,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
848,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
848,3,Immune-mediated lung disease,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
848,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
848,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
849,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
849,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
850,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
850,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
851,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
852,1,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
853,1,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
854,1,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
855,1,Immune-mediated thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
856,1,Adrenal disorder,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,N
856,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
856,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
856,4,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
856,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
856,6,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
856,7,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
856,8,Headache,Headaches NEC,Headaches,Nerv,N
857,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
858,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
859,1,Encephalitis autoimmune,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
860,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
861,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
862,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
862,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
863,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
863,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
863,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
863,4,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
863,5,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
863,6,Oscillopsia,Visual disorders NEC,Vision disorders,Eye,N
864,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
865,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
866,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
866,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
866,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
867,1,Ileal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
867,2,Terminal ileitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
868,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
869,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
870,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
870,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
870,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
871,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
872,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
872,2,Immune-mediated hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
872,3,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
873,1,Empyema,Infections NEC,Infections - pathogen unspecified,Infec,N
874,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
874,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
874,3,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
874,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
874,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
875,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
875,2,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
876,1,Immune-mediated myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
877,1,Immune-mediated myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,Y
877,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
878,1,Immune-mediated myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
879,1,Immune-mediated myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,Y
880,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
880,2,Hyperglycaemic hyperosmolar nonketotic syndrome,Diabetic complications neurological,Diabetic complications,Metab,N
880,3,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
881,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
881,2,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
881,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
881,4,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
881,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
882,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
883,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
883,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
883,3,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
883,4,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
883,5,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
884,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
885,1,Immune-mediated hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
885,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
886,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
887,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
887,2,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
887,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
888,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,Y
889,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
890,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
891,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
891,2,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
891,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
891,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
892,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
893,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
893,2,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
894,1,Immune-mediated thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
894,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
895,1,Cardiac failure acute,Heart failures NEC,Heart failures,Card,Y
895,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
895,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
895,4,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
896,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
896,2,Immune-mediated myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,Y
896,3,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
896,4,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
897,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
897,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
897,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
898,1,Fasciitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
898,2,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
898,3,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
899,1,Blood thyroid stimulating hormone decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
899,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
899,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
899,4,Radiation pneumonitis,Radiation injuries,Injuries by physical agents,Inj&P,N
900,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
901,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
901,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
901,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
901,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
901,5,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
901,6,Hypovolaemic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
901,7,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
901,8,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
901,9,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
901,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
901,11,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
901,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
901,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
902,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
903,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
903,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
904,1,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
905,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
906,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
906,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
907,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
907,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
908,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
909,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
910,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
911,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
912,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
913,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
914,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
915,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
916,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
917,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
918,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
919,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
920,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
921,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
922,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
923,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
924,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
925,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
926,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
927,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
928,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
929,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
930,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
931,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
932,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
933,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
933,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
934,1,Immune-mediated dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
934,2,Immune-mediated thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
934,3,Immune-mediated uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
934,4,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
934,5,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
935,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
936,1,Headache,Headaches NEC,Headaches,Nerv,N
936,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
937,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
938,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
938,2,Immune-mediated myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
938,3,Immune-mediated myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
938,4,Immune-mediated myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
939,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
939,2,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
940,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
941,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
941,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
941,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
941,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
941,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
941,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
941,7,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
941,8,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
941,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
941,10,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
941,11,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
941,12,Migraine,Migraine headaches,Headaches,Nerv,N
941,13,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
941,14,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
941,15,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
941,16,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
941,17,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
942,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
942,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
942,3,Immune-mediated myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,Y
942,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
